Celcuity (CELC) Liabilities and Shareholders Equity (2016 - 2025)

Celcuity (CELC) reported Liabilities and Shareholders Equity of $466.6 million for Q4 2025, up 90.34% on a YoY basis from $245.1 million in Q4 2024, and down 1.98% quarter-over-quarter from $476.0 million in Q3 2025.

Celcuity (CELC) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends

Celcuity has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $466.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 90.34% year-over-year to $466.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 billion (up 34.58% YoY), and the FY2025 full-year result was $466.6 million, up 90.34% from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 stood at $466.6 million, down from $476.0 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $476.0 million in Q3 2025, with the low at $36.4 million in Q1 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $182.3 million across 5 years, with a median of $170.3 million in 2022.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 563.02% — and 2025, when it slumped 37.24%.
  • Celcuity's Liabilities and Shareholders Equity stood at $85.9 million in 2021, then jumped by 104.52% to $175.7 million in 2022, then gained by 8.83% to $191.2 million in 2023, then grew by 28.19% to $245.1 million in 2024, then jumped by 90.34% to $466.6 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $466.6 million (Q4 2025), $476.0 million (Q3 2025), and $183.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 37.37 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 14.93 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 33.89 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 23.64 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.71 Bn 91.71 Bn - 640.56 Mn
10 Celcuity 4.14 Bn 3.42 Bn - 466.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 466.56 Mn
Sep 30, 2025 476.00 Mn
Jun 30, 2025 183.59 Mn
Mar 31, 2025 218.13 Mn
Dec 31, 2024 245.12 Mn
Sep 30, 2024 273.04 Mn
Jun 30, 2024 292.54 Mn
Mar 31, 2024 188.18 Mn
Dec 31, 2023 191.22 Mn
Sep 30, 2023 142.38 Mn
Jun 30, 2023 153.52 Mn
Mar 31, 2023 164.87 Mn
Dec 31, 2022 175.70 Mn
Sep 30, 2022 65.29 Mn
Jun 30, 2022 72.35 Mn
Mar 31, 2022 79.93 Mn
Dec 31, 2021 85.91 Mn
Sep 30, 2021 91.84 Mn
Jun 30, 2021 42.81 Mn
Mar 31, 2021 36.37 Mn